الانتقال الى المحتويات

بدائل نقل الدم توفِّر أكثر مما تكلِّف

جراحة العظام

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). (يفتح نافذة جديدة)

Alshryda S, Mason J, Sarda P, Nargol A, Cooke N, Ahmad H, Tang S, Logishetty R, Vaghela M, McPartlin L, Hungin AP.

Source‎: J Bone Joint Surg Am 2013;95(21):1969-74.

مفهرسة‎: PubMed 24196467

DOI‎: 10.2106/JBJS.L.00908

https://www.ncbi.nlm.nih.gov/pubmed/24196467 (يفتح نافذة جديدة)

Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). (يفتح نافذة جديدة)

Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP.

Source‎: J Bone Joint Surg Am 2013;95(21):1961-8.

مفهرسة‎: PubMed 24196466

DOI‎: 10.2106/JBJS.L.00907

https://www.ncbi.nlm.nih.gov/pubmed/24196466 (يفتح نافذة جديدة)

Multimodal patient blood management program based on a three-pillar strategy: a systematic review and meta-analysis. (يفتح نافذة جديدة)

Althoff FC, Neb H, Herrmann E, Trentino KM, Vernich L, Füllenbach C, Freedman J, Waters JH, Farmer S, Leahy MF, Zacharowski K, Meybohm P, Choorapoikayil S

Source‎: Ann Surg 2019;269(5):794-804.

مفهرسة‎: PubMed 30418206

DOI‎: 10.1097/SLA.0000000000003095

https://www.ncbi.nlm.nih.gov/pubmed/30418206 (يفتح نافذة جديدة)

Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. (يفتح نافذة جديدة)

Berenholtz SM, Pham JC, Garrett-Mayer E, Atchison CW, Kostuik JP, Cohen DB, Nundy S, Dorman T, Ness PM, Klag MJ, Pronovost PJ, Kebaish KM.

Source‎: Spine 2009;34(19):2096-103.

مفهرسة‎: PubMed 19730217

DOI‎: 10.1097/BRS.0b013e3181b1fab2

https://www.ncbi.nlm.nih.gov/pubmed/19730217 (يفتح نافذة جديدة)

An evaluation of the use of topical tranexamic acid in total knee arthroplasty. (يفتح نافذة جديدة)

Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S.

Source‎: J Arthroplasty 2013;28(8 Suppl):74-7.

مفهرسة‎: PubMed 24034510

DOI‎: 10.1016/j.arth.2013.06.037

https://www.ncbi.nlm.nih.gov/pubmed/24034510 (يفتح نافذة جديدة)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (يفتح نافذة جديدة)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

Source‎: J Bone Joint Surg Am 2012;94(21):1952-8.

مفهرسة‎: PubMed 23138237

DOI‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (يفتح نافذة جديدة)

Comparing ε-aminocaproic acid and tranexamic acid in reducing postoperative transfusions in total knee arthroplasty. (يفتح نافذة جديدة)

Churchill JL, Puca KE, Meyer E, Carleton M, Anderson MJ.

Source‎: J Knee Surg 2017;30(5):460-6.

مفهرسة‎: PubMed 27699724

DOI‎: 10.1055/s-0036-1593362

https://www.ncbi.nlm.nih.gov/pubmed/27699724 (يفتح نافذة جديدة)

Process improvement project using tranexamic acid is cost-effective in reducing blood loss and transfusions after total hip and total knee arthroplasty. (يفتح نافذة جديدة)

Demos HA, Lin ZX, Barfield WR, Wilson SH, Robertson DC, Pellegrini VD Jr.

Source‎: J Arthroplasty 2017;32(8):2375-80.

مفهرسة‎: PubMed 28343823

DOI‎: 10.1016/j.arth.2017.02.068

https://www.ncbi.nlm.nih.gov/pubmed/28343823 (يفتح نافذة جديدة)

Clinical and cost effectiveness-related aspects of retransfusion in total hip and knee arthroplasty. (يفتح نافذة جديدة)

Dobosz B, Dutka J, Dutka L, Maleta P.

Source‎: Ortop Traumatol Rehabil 2012;14(5):421-8.

مفهرسة‎: PubMed 23208933

DOI‎: 10.5604/15093492.1016367

https://www.ncbi.nlm.nih.gov/pubmed/23208933 (يفتح نافذة جديدة)

The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. (يفتح نافذة جديدة)

Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, Verma R, Mohammad S, Siddique I.

Source‎: Spine J 2017;17(7):977-82.

مفهرسة‎: PubMed 28323241

DOI‎: 10.1016/j.spinee.2017.03.004

https://www.ncbi.nlm.nih.gov/pubmed/28323241 (يفتح نافذة جديدة)

Effect of tranexamic acid on transfusion rates following total joint arthroplasty: a cost and comparative effectiveness analysis. (يفتح نافذة جديدة)

Evangelista PJ, Aversano MW, Koli E, Hutzler L, Inneh I, Bosco J, Iorio R.

Source‎: Orthop Clin North Am 2017;48(2):109-15.

مفهرسة‎: PubMed 28336035

DOI‎: 10.1016/j.ocl.2016.12.001

https://www.ncbi.nlm.nih.gov/pubmed/28336035 (يفتح نافذة جديدة)

Saving blood and reducing costs: updating blood transfusion practice in lower limb arthroplasty. (يفتح نافذة جديدة)

Fenelon C, Galbraith JG, Kearsley R, Motherway C, Condon F, Lenehan B.

Source‎: Ir Med J 2018;111(4):730.

مفهرسة‎: PubMed 30465599

https://www.ncbi.nlm.nih.gov/pubmed/30465599 (يفتح نافذة جديدة)

Methods of bloodless care, clinical outcomes, and costs for adult patients who decline allogeneic transfusions. (يفتح نافذة جديدة)

Frank SM, Pippa A, Sherd I, Scott AV, Lo BD, Cruz NC, Hendricks EA, Ness PM, Chaturvedi S, Resar LMS.

Source‎: Anesth Analg 2022;135(3):576-85.

مفهرسة‎: PubMed 35977366

DOI‎: 10.1213/ANE.0000000000006114

https://www.ncbi.nlm.nih.gov/pubmed/35977366 (يفتح نافذة جديدة)

Tranexamic acid decreases blood loss after total shoulder arthroplasty. (يفتح نافذة جديدة)

Friedman RJ, Gordon E, Butler RB, Mock L, Dumas B.

Source‎: J Shoulder Elbow Surg 2016;25(4):614-8.

مفهرسة‎: PubMed 26652697

DOI‎: 10.1016/j.jse.2015.09.014

https://www.ncbi.nlm.nih.gov/pubmed/26652697 (يفتح نافذة جديدة)

Restrictive versus liberal red blood cell transfusion strategy after hip surgery: a decision model analysis of healthcare costs. (يفتح نافذة جديدة)

Fusaro MV, Nielsen ND, Nielsen A, Fontaine MJ, Hess JR, Reed RM, DeLisle S, Netzer G.

Source‎: Transfusion 2017;57(2):357-66.

مفهرسة‎: PubMed 28019009

DOI‎: 10.1111/trf.13936

https://www.ncbi.nlm.nih.gov/pubmed/28019009 (يفتح نافذة جديدة)

Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. (يفتح نافذة جديدة)

Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, Sierra RJ.

Source‎: J Arthroplasty 2013;28(8 Suppl):137-9.

مفهرسة‎: PubMed 23886409

DOI‎: 10.1016/j.arth.2013.04.054

https://www.ncbi.nlm.nih.gov/pubmed/23886409 (يفتح نافذة جديدة)

Cell saver for adult spinal deformity surgery reduces cost. (يفتح نافذة جديدة)

Gum JL, Carreon LY, Kelly MP, Hostin R, Robinson C, Burton DC, Polly DW, Shaffrey CI, LaFage V, Schwab FJ, Ames CP, Kim HJ, Smith JS, Bess RS; International Spine Study Group.

Source‎: Spine Deform 2017;5(4):272-6.

مفهرسة‎: PubMed 28622903

DOI‎: 10.1016/j.jspd.2017.01.005

https://www.ncbi.nlm.nih.gov/pubmed/28622903 (يفتح نافذة جديدة)

Tranexamic acid in patients with cancer undergoing endoprosthetic reconstruction: a cost analysis. (يفتح نافذة جديدة)

Haase DR, Kimbrel B, Bombardier B, Templeton KJ, Rosenthal HG, Sweeney KR.

Source‎: J Am Acad Orthop Surg 2021;29(22):961-9.

مفهرسة‎: PubMed 34570739

DOI‎: 10.5435/JAAOS-D-20-00971

https://www.ncbi.nlm.nih.gov/pubmed/34570739 (يفتح نافذة جديدة)

Topically applied epsilon-aminocaproic acid reduces blood loss and length of hospital stay after total knee arthroplasty. (يفتح نافذة جديدة)

Harper RA, Sucher MG, Giordani M, Nedopil AJ.

Source‎: Orthopedics 2017;40(6):e1044-9.

مفهرسة‎: PubMed 28968480

DOI‎: 10.3928/01477447-20170925-07

https://www.ncbi.nlm.nih.gov/pubmed/28968480 (يفتح نافذة جديدة)

Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. (يفتح نافذة جديدة)

Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F.

Source‎: Orthop Traumatol Surg Res 2012;98(5):477-83.

مفهرسة‎: PubMed 22854336

DOI‎: 10.1016/j.otsr.2012.05.002

https://www.ncbi.nlm.nih.gov/pubmed/22854336 (يفتح نافذة جديدة)

Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. (يفتح نافذة جديدة)

Leahy MF, Hofmann A, Towler S, Trentino KM, Burrows SA, Swain SG, Hamdorf J, Gallagher T, Koay A, Geelhoed GC, Farmer SL.

Source‎: Transfusion 2017;57(6):1347-58.

مفهرسة‎: PubMed 28150313

DOI‎: 10.1111/trf.14006

https://www.ncbi.nlm.nih.gov/pubmed/28150313 (يفتح نافذة جديدة)

Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. (يفتح نافذة جديدة)

Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D.

Source‎: Br J Anaesth 2007;99(6):794-800.

مفهرسة‎: PubMed 17928302

DOI‎: 10.1093/bja/aem266

https://www.ncbi.nlm.nih.gov/pubmed/17928302 (يفتح نافذة جديدة)

Are allogeneic transfusions decreasing in total knee arthroplasty patients? National Inpatient Sample 2009-2013. (يفتح نافذة جديدة)

Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, Delanois RE.

Source‎: J Arthroplasty 2018;33(6):1705-12.

مفهرسة‎: PubMed 29352682

DOI‎: 10.1016/j.arth.2017.12.014

https://www.ncbi.nlm.nih.gov/pubmed/29352682 (يفتح نافذة جديدة)

Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. (يفتح نافذة جديدة)

Moskal JT, Harris RN, Capps SG.

Source‎: J Arthroplasty 2015;30(3):365-8.

مفهرسة‎: PubMed 25458093

DOI‎: 10.1016/j.arth.2014.10.008

https://www.ncbi.nlm.nih.gov/pubmed/25458093 (يفتح نافذة جديدة)

The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. (يفتح نافذة جديدة)

Muñoz M, Ariza D, Campos A, Martín-Montañez E, Pavía J.

Source‎: Blood Transfus 2013;11(2):260-71.

مفهرسة‎: PubMed 23149145

DOI‎: 10.2450/2012.0139-12

https://www.ncbi.nlm.nih.gov/pubmed/23149145 (يفتح نافذة جديدة)

Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. (يفتح نافذة جديدة)

Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J.

Source‎: Blood Transfus 2014;12(1):40-9.

مفهرسة‎: PubMed 24120595

DOI‎: 10.2450/2013.0088-13

https://www.ncbi.nlm.nih.gov/pubmed/24120595 (يفتح نافذة جديدة)

Blood loss control with two doses of tranexamic acid in a multimodal protocol for total knee arthroplasty. (يفتح نافذة جديدة)

Ortega-Andreu M, Pérez-Chrzanowska H, Figueredo R, Gómez-Barrena E.

Source‎: Open Orthop J 2011;5:44-8.

مفهرسة‎: PubMed 21552468

DOI‎: 10.2174/1874325001105010044

https://www.ncbi.nlm.nih.gov/pubmed/21552468 (يفتح نافذة جديدة)

Cost analysis of tranexamic acid in anemic total joint arthroplasty patients. (يفتح نافذة جديدة)

Phan DL, Ani F, Schwarzkopf R.

Source‎: J Arthroplasty 2016;31(3):579-82.

مفهرسة‎: PubMed 26601635

DOI‎: 10.1016/j.arth.2015.10.001

https://www.ncbi.nlm.nih.gov/pubmed/26601635 (يفتح نافذة جديدة)

One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. (يفتح نافذة جديدة)

Ralley FE, Berta D, Binns V, Howard J, Naudie DD.

Source‎: Clin Orthop Relat Res 2010;468(7):1905-11.

مفهرسة‎: PubMed 20063079

DOI‎: 10.1007/s11999-009-1217-8

https://www.ncbi.nlm.nih.gov/pubmed/20063079 (يفتح نافذة جديدة)

Pharmacologic hemostatic agents in total joint arthroplasty--a cost-effectiveness analysis. (يفتح نافذة جديدة)

Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti WE.

Source‎: J Arthroplasty 2018;33(7):2092-9.e9.

مفهرسة‎: PubMed 29605152

DOI‎: 10.1016/j.arth.2018.02.068

https://www.ncbi.nlm.nih.gov/pubmed/29605152 (يفتح نافذة جديدة)

Efficacy and cost-effectiveness of cell saving blood autotransfusion in adult lumbar fusion. (يفتح نافذة جديدة)

Savvidou C, Chatziioannou SN, Pilichou A, Pneumaticos SG.

Source‎: Transfus Med 2009;19(4):202-6.

مفهرسة‎: PubMed 19706137

DOI‎: 10.1111/j.1365-3148.2009.00929.x

https://www.ncbi.nlm.nih.gov/pubmed/19706137 (يفتح نافذة جديدة)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (يفتح نافذة جديدة)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

Source‎: Int Orthop 2019;43(12):2707-14.

مفهرسة‎: PubMed 30671601

DOI‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (يفتح نافذة جديدة)

Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. (يفتح نافذة جديدة)

Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M.

Source‎: J Orthop Surg Res 2011;6:22.

مفهرسة‎: PubMed 21600028

DOI‎: 10.1186/1749-799X-6-22

https://www.ncbi.nlm.nih.gov/pubmed/21600028 (يفتح نافذة جديدة)

Increased hospital costs associated with red blood cell transfusion. (يفتح نافذة جديدة)

Trentino KM, Farmer SL, Swain SG, Burrows SA, Hofmann A, Ienco R, Pavey W, Daly FF, Van Niekerk A, Webb SA, Towler S, Leahy MF.

Source‎: Transfusion 2015;55(5):1082-9.

مفهرسة‎: PubMed 25488623

DOI‎: 10.1111/trf.12958

https://www.ncbi.nlm.nih.gov/pubmed/25488623 (يفتح نافذة جديدة)

Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. (يفتح نافذة جديدة)

Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE.

Source‎: J Arthroplasty 2014;29(8):1512-5.

مفهرسة‎: PubMed 24630599

DOI‎: 10.1016/j.arth.2014.01.031

https://www.ncbi.nlm.nih.gov/pubmed/24630599 (يفتح نافذة جديدة)

Clinical and budget impact of treating preoperative anemia in major orthopedic surgery--a retrospective observational study. (يفتح نافذة جديدة)

Wan S, Sparring V, Cabrales DA, Jansson KÅ, Wikman A.

Source‎: J Arthroplasty 2020;35(11):3084-8.

مفهرسة‎: PubMed 32654943

DOI‎: 10.1016/j.arth.2020.06.018

https://www.ncbi.nlm.nih.gov/pubmed/32654943 (يفتح نافذة جديدة)

The effectiveness of reinfusion after total knee replacement. A prospective randomised controlled study. (يفتح نافذة جديدة)

Zacharopoulos A, Apostolopoulos A, Kyriakidis A.

Source‎: Int Orthop 2007;31(3):303-8.

مفهرسة‎: PubMed 16810542

DOI‎: 10.1007/s00264-006-0173-0

https://www.ncbi.nlm.nih.gov/pubmed/16810542 (يفتح نافذة جديدة)

بدائل نقل الدم توفِّر أكثر مما تكلِّف
جراحة العظام
العربية
جراحة العظام
https://assetsnffrgf-a.akamaihd.net/assets/ct/d8f8c0370e/images/syn_placeholder_sqr.png

لجنة الاتصال بالمستشفيات (‏ل‌ام)‏

إتصل بأحد أفراد لجنة الاتصال بالمستشفيات المحلية التي تقدِّم لك المساعدة مجانًا.‏

اتصل بنا

رُزَم معلومات للأطباء

من جملة المواضيع:‏ تقنيات وإستراتيجيات لإيقاف النزف ومعالجة الأنيميا دون نقل دم،‏ موقف شهود يهوه الديني والأخلاقي من المعالجة الطبية،‏ والمساعدة التي يقدِّمونها للأطباء حول العالم عبر لجان الاتصال بالمستشفيات.‏

نزِّل المراجع

الفيديوات

تقترح هذه الفيديوات علاجات بديلة لنقل الدم.‏ وتلفت النظر الى المسائل الطبية والاخلاقية التي يلزم ان يأخذها الاطباء في الاعتبار حين يعالجون شهود يهوه.‏

شاهِد الفيديوات